APONVIE FDA approval date

The FDA approved APONVIE on 16 Sep 2022.

FDA approval date
16 Sep 2022

Drug identity has not yet been verified against registry records

Also recorded as APREPITANT

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-09-16DayAPONVIEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA216457", "applicant_as_listed_by_fda": "HERON THERAPS INC", "brand_names": ["APONVIE"], "active_ingredients": ["APREPITANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220916", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026